Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
- PMID: 22169064
- PMCID: PMC3388659
- DOI: 10.1186/cc10527
Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
Abstract
Reversing the immunoparalysis associated with septic shock remains a priority for improving the outcome of patients suffering from sepsis. The efficacy of future therapies may be better studied under an effective system of patient stratification. Gene expression biomarkers offer a mechanism by which patients may be appropriately stratified in such clinical trials.
Comment on
-
mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance.Crit Care. 2011;15(5):R252. doi: 10.1186/cc10513. Epub 2011 Oct 25. Crit Care. 2011. PMID: 22027436 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
